A blend of 3 mushrooms dose-dependently increases butyrate production by the gut microbiota
Open Access
- 16 November 2021
- journal article
- research article
- Published by Brill in Beneficial Microbes
- Vol. 12 (6), 601-612
- https://doi.org/10.3920/bm2021.0015
Abstract
The gut microbiota has been indicated to play a crucial role in health and disease. Apart from changes in composition between healthy individuals and those with a disease or disorder, it has become clear that also microbial activity is important for health. For instance, butyrate has been proven to be beneficial for health, because, amongst others, it is a substrate for the colonocytes, and modulates the host’s immune system and metabolism. Here, we studied the effect of a blend of three mushrooms (Ganoderma lucidum GL AM P-38, Grifola frondosa GF AM P36 and Pleurotus ostreatus PO AM-GP37)) on gut microbiota composition and activity in a validated, dynamic, computer-controlled in vitro model of the colon (TIM-2). Predigested mushroom blend at three doses (0.5, 1.0 and 1.5 g/day of ingested mushroom blend) was fed to a pooled microbiota of healthy adults for 72 h, and samples were taken every day for microbiota composition (sequencing of amplicons of the V3-V4 region of the 16S rRNA gene) and activity (short-chain fatty acid (SCFA) production). The butyrate producing genera Lachnospiraceae UCG-004, Lachnoclostridium, Ruminococcaceae UCG-002 and Ruminococcaceae NK4A214-group are all dose-dependently increased when the mushroom blend was fed. Entirely in line with the increase of these butyrate-producers, the cumulative amount of butyrate also dose-dependently increased, to roughly twice the amount compared to the control (medium without mushroom blend) on the high-dose mushroom blend. Butyrate proportionally made up 53.1% of the total SCFA upon feeding the high-dose mushroom blend, compared to 27% on the control medium. In conclusion, the (polysaccharides in the) mushroom blend led to substantial increase in butyrate by the gut microbiota. These results warrant future mechanistic research on the mushroom blend, as butyrate is considered to be one of the microbial metabolites that contributes to health, by increasing barrier function and modulating inflammation.Keywords
This publication has 85 references indexed in Scilit:
- Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebioticsBeneficial Microbes, 2014
- Mini-review on edible mushrooms as source of dietary fiber: Preparation and health benefitsFood Science and Human Wellness, 2013
- Measuring non-steady-state metabolic fluxes in starch-converting faecal microbiota in vitroBeneficial Microbes, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Profiling human gut bacterial metabolism and its kinetics using [U-13C]glucose and NMRNMR in Biomedicine, 2009
- Structural elucidation of the polysaccharide moiety of a glycopeptide (GLPCW-II) from Ganoderma lucidum fruiting bodiesCarbohydrate Research, 2008
- Review article: the role of butyrate on colonic functionAlimentary Pharmacology & Therapeutics, 2007
- The gut microbiota as an environmental factor that regulates fat storageProceedings of the National Academy of Sciences of the United States of America, 2004
- A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation productsApplied Microbiology and Biotechnology, 1999
- Short chain fatty acids in human large intestine, portal, hepatic and venous blood.Gut, 1987